A CpG-methylation-based assay to predict survival in clear cell renal cell carcinoma.
about
An integrative study on the impact of highly differentially methylated genes on expression and cancer etiologyMethylomes of renal cell lines and tumors or metastases differ significantly with impact on pharmacogenesSignificant impact of amount of PCR input templates on various PCR-based DNA methylation analysis and countermeasure.Genome-wide association studies and epigenome-wide association studies go together in cancer control.The epigenetic landscape of renal cancer.DNA methylation aberrancies as a guide for surveillance and treatment of human cancers.RIN1 promotes renal cell carcinoma malignancy by activating EGFR signaling through Rab25Promoter DNA methylation analysis reveals a novel diagnostic CpG-based biomarker and RAB25 hypermethylation in clear cell renel cell carcinoma.Identification of key genes in endometrioid endometrial adenocarcinoma via TCGA database.A seven-gene prognostic signature for rapid determination of head and neck squamous cell carcinoma survival.Integrative analysis of the epigenetic basis of muscle-invasive urothelial carcinoma.Intragenic DNA methylation of PITX1 and the adjacent long non-coding RNA C5orf66-AS1 are prognostic biomarkers in patients with head and neck squamous cell carcinomas.Abnormal PITX1 gene methylation in adolescent idiopathic scoliosis: a pilot study.Identification of potential pathogenic biomarkers in clear cell renal cell carcinoma.Fifteen-gene expression based model predicts the survival of clear cell renal cell carcinoma
P2860
Q36274178-14F4CA4E-859E-409C-8BA9-D2BAF6BF28FBQ37110909-2BED8863-16E5-4C17-A5C8-59598EE57DCDQ37636644-FD1FBD77-76AC-4F18-894B-1DA4A1C2265BQ38881089-94BFE7D9-A4AE-434A-BD2B-825B371458D0Q39021700-45CF7DC2-4B12-41C2-AB93-AF5B07F84F75Q39208639-CEB3A968-6F05-4617-B466-2003E9EDED4CQ41247591-CCAF8224-8643-4193-BC0E-94467228F1F8Q47123355-A9A8AF72-2821-4F21-80D4-123AFC9B4B15Q47737163-7DE0C54F-9A47-42FD-B52E-4C2D3E69BDD9Q49525456-2C8B8017-BCCF-4797-A1B1-22389F64BB37Q49874623-A50418F7-BE6B-4F04-9D9A-1AD46E6BAA79Q50099281-93A0E746-C58B-4269-B123-208D9C1E12A4Q55000869-5917AC5D-C7C3-44C1-AA54-1E298776B3D9Q55190197-35942B41-50CF-497F-91D4-51C5FCD072CEQ58768539-28F043E5-3655-4435-9B2D-371BE3997869
P2860
A CpG-methylation-based assay to predict survival in clear cell renal cell carcinoma.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
A CpG-methylation-based assay to predict survival in clear cell renal cell carcinoma.
@en
type
label
A CpG-methylation-based assay to predict survival in clear cell renal cell carcinoma.
@en
prefLabel
A CpG-methylation-based assay to predict survival in clear cell renal cell carcinoma.
@en
P2093
P2860
P356
P1476
A CpG-methylation-based assay to predict survival in clear cell renal cell carcinoma.
@en
P2093
Ahmed Haddad
Cai-Xia Li
Fang-Jian Zhou
Hong-Wei Zhao
Jer-Tsong Hsieh
Jian-Cheng Zhou
P2860
P2888
P356
10.1038/NCOMMS9699
P407
P577
2015-10-30T00:00:00Z